| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,781,000 | 1,766,000 | 1,477,000 | 2,433,000 | | Cost of Revenue | 1,420,000 | 1,440,000 | 1,283,000 | 1,935,000 | | | Gross Profit | 361,000 | 326,000 | 194,000 | 498,000 | | | Operating Expenses | | Research Development | 81,000 | 79,000 | 110,000 | 120,000 | | Selling General and Administrative | 315,000 | 329,000 | 311,000 | 403,000 | | Non Recurring | 46,000 | 37,000 | 109,000 | 880,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (81,000) | (119,000) | (336,000) | (905,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | 14,000 | (15,000) | 17,000 | | Earnings Before Interest And Taxes | (72,000) | (105,000) | (351,000) | (888,000) | | Interest Expense | 27,000 | 23,000 | 25,000 | 28,000 | | Income Before Tax | (99,000) | (128,000) | (376,000) | (916,000) | | Income Tax Expense | 12,000 | 63,000 | (16,000) | (2,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (111,000) | (191,000) | (360,000) | (914,000) | | | Non-recurring Events | | Discontinued Operations |
-
| (4,000) | 7,000 | (4,000) | | Extraordinary Items |
-
| 6,000 |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (111,000) | (189,000) | (353,000) | (918,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($111,000) | ($189,000) | ($353,000) | ($918,000) |
|
0.29% Nasdaq 
Income Statement
